When Should We Start Sodium–Glucose Co-transporter Inhibitors in Patients with Heart Failure? The Importance of Early Intervention

When Should We Start Sodium–Glucose Co-transporter Inhibitors in Patients with Heart Failure? The Importance of Early Intervention

Saved in:

Bibliographic Details
Main Authors:	Moritake Iguchi, Hiromichi Wada, Felipe Martínez, Koji Hasegawa
Format:	Article
Language:	English
Published:	Radcliffe Medical Media 2023-06-01
Series:	European Cardiology Review
Online Access:	https://www.ecrjournal.com/articleindex/ecr.2022.62
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

When Should We Stop Breeding Dairy Cows?
by: Klibs N. Galvão, et al.
Published: (2014-09-01)

When Should We Stop Breeding Dairy Cows?
by: Klibs N. Galvão, et al.
Published: (2014-09-01)

Efficacy of sodium-glucose co-transporter-2 inhibitors in patients with heart failure
by: E. V. Kovalenko, et al.
Published: (2021-02-01)

Effects of Sodium–Glucose Cotransporter 2 Inhibitors on Calcium Homeostasis: Where We Stand Now
by: Alessandro Cuttone, et al.
Published: (2025-05-01)

Challenging the Restrictive Approach: Reconsidering Sodium-Glucose Transport Protein 2 Inhibitor Use in CKD
by: Ozant Helvaci, et al.
Published: (2024-06-01)

Teaching Beginners to Program: should we start with block-based, text-based, or both notations?
by: Tomaž Kosar, et al.
Published: (2024-10-01)

Should Dalysis be Started Late?
by: Meltem Gürsu, et al.
Published: (2011-12-01)

The Effect of Dapagliflozin, a Sodium–Glucose Co-Transporter 2 Inhibitor, on Vancomycin-Induced Nephrotoxicity in Rats
by: Seyhmus Tan, et al.
Published: (2025-06-01)

Metabolic reprogramming as the basis for sodium-glucose co-transporter type 2 inhibitors cardio- and nephroprotective effect
by: O N. Kurochkina, et al.
Published: (2024-06-01)

What should we do for the safe transportation of COVID-19 patients?
by: Masayuki Akatsuka, et al.
Published: (2020-11-01)

Cellular Agriculture for Production of Cell-Based Seafood: Part 2— Why should we start with lean fish?
by: Rose Omidvar, et al.
Published: (2023-12-01)

REBOA for trauma: Could we? Should we?
by: Matthew DeLaney, et al.
Published: (2020-10-01)

Sodium-glucose cotransporter 2 inhibitors as potential anticancer agents
by: E. R. Radkevich, et al.
Published: (2025-05-01)

A New Chapter in the Treatment of Patients with Heart Failure. The Role of Sodium-Glucose Co-transporter Type 2 Inhibitors
by: D. P. Golubovskaya, et al.
Published: (2022-11-01)

Should We Go Organic?
by: Kate Welch, et al.
Published: (2012-08-01)

Should We Go Organic?
by: Kate Welch, et al.
Published: (2012-08-01)

Hormone Therapy — When to start and when to stop?
by: F. Guidozzi
Published: (2005-04-01)

Should we Build Mega Transport Project in Cities? The Case of TransPeshawar Pakistan
by: Sayed Fayaz Ahmad, et al.
Published: (2019-06-01)

When we should worry more: using cognitive bias modification to drive adaptive health behaviour.
by: Lies Notebaert, et al.
Published: (2014-01-01)

The end we start from /
by: Hunter, Megan
Published: (2017)

Sodium-Glucose Cotransporter 2 Inhibitors in Diabetic Kidney Disease and beyond
by: Zein Alabdin Hannouneh, et al.
Published: (2025-01-01)

Sodium–Glucose Cotransporter-2 Inhibitors After Acute Myocardial Infarction
by: Nicia I. Profili, et al.
Published: (2025-03-01)

Antifibrotic effects of sodium-glucose cotransporter 2 inhibitors in patients with heart failure
by: Yu. S. Ignatova, et al.
Published: (2024-02-01)

Sodium-Glucose Cotransporter 2 Inhibitors Improve Chronic Diabetic Macular Edema
by: Yoko Takatsuna, et al.
Published: (2020-01-01)

Cardioprotective effects of sodium-glucose transport protein 2 inhibitors in patients with breast cancer and concomitant type 2 diabetes mellitus undergoing chemotherapy
by: S.V. Fedorov, et al.
Published: (2025-05-01)

WCN24-1354 Worldwide Use of Sodium Glucose Co-transporter 2 Inhibitors in Immunoglobulin A nephropathy: A country and Regional Analysis
by: Chee Kay Cheung, et al.
Published: (2024-04-01)

Euglycemic diabetic ketoacidosis associated with a sodium-glucose co transporter 2 inhibitor use in a trauma patient: a case report
by: Ophélie Dirand, et al.
Published: (2025-08-01)

Effect of Sodium-Glucose Cotransporter Type 2 Inhibitors on The Development and Course of Atrial Fibrillation
by: D. A. Ishmaev, et al.
Published: (2025-01-01)

Evaluation of factors influencing adherence to treatment with sodium-glucose cotransporter type 2 inhibitor
by: D. A. Lebedev, et al.
Published: (2020-10-01)

Role of sodium-glucose cotransporter 2 inhibitors in cardiovascular events in patients with heart failure
by: Eva Muja, et al.
Published: (2025-07-01)

Protective Potential of Sodium-Glucose Cotransporter 2 Inhibitors in Internal Medicine (Part 2)
by: Ashot A. Avagimyan, et al.
Published: (2025-02-01)

An Elderly Comorbid Patient with Atrial Fibrillation: What is Important to Know and What Should be Considered When Prescribing Anticoagulants?
by: T. V. Pavlova
Published: (2020-12-01)

ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN ACUTE MYOCARDIAL INFARCTION: WHEN TO START THERAPY AND WHICH DRUG TO USE?
by: S. Y. Martsevich, et al.
Published: (2015-12-01)

PO32 | Effect of the sodium-glucose co-transporter-2 (SGLT2) inhibitors on platelet activation and lipid peroxidation: results of a pilot study
Published: (2025-08-01)

Effect of sodium-glucose cotransporter 2 inhibitors on ventricular function in systemic right ventricular failure
by: Lorna Swan, et al.
Published: (2025-07-01)

Sodium–Glucose Cotransporter 2 Inhibitors as Potential Antioxidant Therapeutic Agents in Cardiovascular and Renal Diseases
by: Tapan A. Patel, et al.
Published: (2025-03-01)

Diagnosis of spondyloarthritis: should we need new criteria?
by: I. Z. Gaidukova, et al.
Published: (2015-03-01)

SHOULD WE PROTECT THE CHILDREN AGAINST PNEUMOCOCCAL INFECTION?
by: A.A. Baranov, et al.
Published: (2008-01-01)

Impact of Sodium-Glucose Cotransporter-2 Inhibitors on Post-Transurethral Resection of Bladder Tumor Infection and Prognosis
by: Nobutaka Nishimura, et al.
Published: (2025-07-01)

When to start antibiotic therapy in patients with sepsis in the ICU?
by: V. A. Rudnov, et al.
Published: (2020-11-01)